DBC2, a candidate for a tumor suppressor gene involved in breast cancer

A previously uncharacterized gene, DBC2 (deleted in breast cancer), was cloned from a homozygously deleted region at human chromosome 8p21. DBC2 contains a highly conserved RAS domain and two putative protein interacting domains. Our analyses indicate that DBC2 is the best candidate tumor suppressor gene from this region. It lies within the epicenter of the deletions and is homozygously deleted in 3.5% (7/200) of breast tumors. Mutation analysis of DBC2 led to discovery of two instances of somatic missense mutations in breast tumor specimens, whereas no missense mutations were found in other candidates from the region. Unlike other genes in the region, expression of DBC2 is often extinguished in breast cancer cells or tissues. Moreover, our functional analysis revealed that DBC2 expression in breast cancer cells lacking DBC2 transcripts causes growth inhibition. By contrast, expression of a somatic mutant discovered in a breast cancer specimen does not suppress the growth of breast cancer cells.

[1]  M. Wigler,et al.  Design of a retroviral-mediated ecdysone-inducible system and its application to the expression profiling of the PTEN tumor suppressor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[3]  W. El-Deiry,et al.  Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site , 2000, Oncogene.

[4]  J. Gray,et al.  Genome changes and gene expression in human solid tumors. , 2000, Carcinogenesis.

[5]  H. S. Kim,et al.  Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers. , 1999, Cancer research.

[6]  Andrew Smith.  Genome sequence of the nematode C-elegans: A platform for investigating biology , 1998 .

[7]  I. Bièche,et al.  Novel approach to quantitative polymerase chain reaction using real‐time detection: Application to the detection of gene amplification in breast cancer , 1998, International journal of cancer.

[8]  J. Milbrandt,et al.  Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3 , 1998, Nature Genetics.

[9]  J W Gray,et al.  Genetic analysis using genomic representations. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. A. O'Connor,et al.  Rapid isolation of cDNA by hybridization. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[12]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[13]  Carissa A. Sanchez,et al.  Comparative genomic analysis of tumors: detection of DNA losses and amplification. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Treisman,et al.  The POZ domain: a conserved protein-protein interaction motif. , 1994, Genes & development.

[15]  M. Gorovsky,et al.  Mapping the 5' and 3' ends of Tetrahymena thermophila mRNAs using RNA ligase mediated amplification of cDNA ends (RLM-RACE). , 1993, Nucleic acids research.

[16]  T. Sugimura,et al.  Establishment of a highly sensitive and specific exon-trapping system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[18]  T. Sekiya,et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. V. Ommen,et al.  The protein truncation test: A review. , 1999 .

[20]  Ash A. Alizadeh,et al.  Genome-wide analysis of DNA copy-number changes using cDNA microarrays , 1999 .

[21]  D. Bishop.  BRCA1 and BRCA2 and breast cancer incidence: a review. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.